title: Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer.
abstract: BACKGROUND
  Postoperative atrial fibrillation (AF) is a complication of thoracic surgery for lung cancer, with a reported incidence that can run as high as 42%. Recently, it has been observed retrospectively that B-type natriuretic peptide predicts AF after cardiac surgery. We performed a prospective study to evaluate the role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) as a marker for risk stratification of postoperative AF in patients undergoing thoracic surgery for lung cancer.
  
  
  RESULTS
  We measured NT-proBNP levels in 400 patients (mean age, 62+/-10 years; 271 men) 24 hours before and 1 hour after surgery. The primary end point of the study was the incidence of postoperative AF. Overall, postoperative AF occurred in 72 patients (18%). Eighty-eight patients (22%) showed an elevated perioperative NT-proBNP value. When patients with either preoperatively or postoperatively elevated NT-proBNP were pooled, a greater incidence of AF was observed compared with patients with normal values (64% versus 5%; P<0.001). At multivariable analysis, adjusted for age, gender, major comorbidities, echocardiography parameters, pneumonectomy, and medications, both preoperative and postoperative NT-proBNP values were independent predictors of AF (relative risk, 27.9; 95% CI, 13.2 to 58.9; P<0.001 for preoperative NT-proBNP elevation; relative risk, 20.1; 95% CI, 5.8 to 69.4; P<0.001 for postoperative NT-proBNP elevation).
  
  
  CONCLUSIONS
  Elevation of perioperative NT-proBNP is a strong independent predictor of postoperative AF in patients undergoing thoracic surgery for lung cancer. This finding should facilitate studies of therapies to reduce AF in selected high-risk patients.
authors.affiliation: Cardiology Unit, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy. daniela.cardinale@ieo.it
authors.forename: Daniela
authors.initials: D
authors.lastname: Cardinale
authors.forename: Alessandro
authors.initials: A
authors.lastname: Colombo
authors.forename: Maria T
authors.initials: MT
authors.lastname: Sandri
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Lamantia
authors.forename: Nicola
authors.initials: N
authors.lastname: Colombo
authors.forename: Maurizio
authors.initials: M
authors.lastname: Civelli
authors.forename: Michela
authors.initials: M
authors.lastname: Salvatici
authors.forename: Giulia
authors.initials: G
authors.lastname: Veronesi
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Veglia
authors.forename: Cesare
authors.initials: C
authors.lastname: Fiorentini
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Spaggiari
authors.forename: Carlo M
authors.initials: CM
authors.lastname: Cipolla
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood* / Q000453:epidemiology*; D009320:Atrial Natriuretic Factor / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D015994:Incidence; D007432:Intraoperative Period; D008175:Lung Neoplasms / Q000453:epidemiology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood* / Q000453:epidemiology*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011498:Protein Precursors / Q000097:blood*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D019616:Thoracic Surgical Procedures / Q000706:statistics & numerical data
chemical_list: D015415:Biomarkers; C099254:N-terminal proatrial natriuretic peptide; D011498:Protein Precursors; D009320:Atrial Natriuretic Factor